Clinical Trials Browser

Phase 2/3 × Neoplasms, Plasma Cell × 90 days × Clear all

NCT07319897 2026-01-06

A Prospective, Multicenter, Diagnostic Study Evaluating 68Ga-BCMA PET/CT for Targeting BCMA Expression in Multiple Myeloma.

Phase 2/3 Not yet recruiting

Disease, Multiple Myeloma, Neoplasms, Plasma Cell